611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
Long COVID Can Last a Year; Many Sufferers Quit JobsWould You Like Phthalates With That? Fast Food Contains Industrial Chemicals: ReportMany Blood Cancer Patients Get Little Protection From COVID VaccineMerck Allows Poor Nations to Make COVID-19 PillHow Folks Are Coping With Post-COVID Loss of Smell, TasteRoutine Ventilation of Surgical Patients Won't Raise COVID Transmission RiskImmunocompromised May Need Fourth COVID Shot: CDCLiver Transplants Soar as Some Americans Drink Their Way Through the PandemicFDA Advisors Approve Emergency Use of Pfizer COVID Vaccine in Kids 5 to 11COVID Vaccination Can Be Safe Even in People With Severe AllergiesTargeted High-Dose Radiation Helps Fight Advanced Lung CancerTrader Joe's Salami Snacks Tied to 20 Salmonella Cases in 8 StatesWhite House Takes More Steps to Boost Supply of Rapid at-Home COVID TestsBiden Administration Announces Details of Vaccination Requirements for Foreign TravelersAHA News: Never Heard of Sepsis? It's Common, Dangerous and a Threat to Your HeartModerna Says Its COVID Vaccine Works Well in Children Aged 6 to 11COVID Vaccination Does Not Raise Odds of Miscarriage: StudyVaccinated People Less Likely to Die of Any Cause in Months After Shots: CDCRecovering COVID Patients Often Face Long-Term 'Brain Fog'COVID Pandemic May Have Driven a Flu Strain Into ExtinctionThe No. 1 Cause of Halloween Injuries: Carving the PumpkinPfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDAPfizer Says Lower Dose of Its COVID Vaccine Protects Younger ChildrenDeadly Liver Disease Tied to Obesity Is on the RiseCDC Signs Off on Moderna, J&J Boosters, Backs Mix n' Match ShotsMoving Monoclonal Antibody Treatments for COVID From Hospital to HomeConfusion, Seizures: People Hospitalized After Taking Veterinary Drug for COVIDMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyPfizer Vaccine Booster Restores Nearly Full Protection, Company SaysTen Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune DiseaseSex of Fetus May Matter When COVID Strikes in PregnancyVaccines Cut Odds for Death From COVID Delta Variant by 90%U.S. Has Shared 200 Million Shots With Other CountriesSalmonella Outbreak in 37 States Linked to Imported OnionsFDA Approves Moderna, J&J Booster Shots, Backs Mix n' Match VaccinesWhite House Announces COVID Vaccination Plan for Young KidsEven With Mild COVID, Obesity May Mean Worse SymptomsNew Device Might Spot 'Lazy Eye' in Kids EarlierA High-Tech Pointer to Pollutants That Trigger Asthma in KidsFlu Cases Already Up 23% This Season: WalgreensDoctors Report That Kidney Grown in Pig Worked in a HumanHeartburn Meds Might Be Good for Your GumsOne Big Factor for Survival After Spinal Cord Injury: ResilienceDying Young From Heart Disease: Where You Live in the U.S. MattersFDA Expected to Allow Mix n' Match COVID VaccinesPowell's COVID Death Despite Vaccination Shows Danger to Those With Weakened Immune SystemsAHA News: Your Next Doctor's Prescription Might Be to Spend Time in NatureOut-of-Pocket Medical Bills for COVID-19 May Average $3,800 in 2021: StudyLegionnaires' Disease Outbreak Hits Long Island, N.Y.State Lotteries Didn't Help Boost Vaccination Rates
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Cancer Care Costs U.S. $156 Billion Per Year; Drugs a Major Factor

HealthDay News
by Robert Preidt
Updated: Oct 13th 2021

new article illustration

WEDNESDAY, Oct. 13, 2021 (HealthDay News) -- Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers.

Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State College of Medicine study.

"The public often hears that the U.S. spends an inordinate amount of money on health care, but no one has quantified exactly how big that number is and how that number [is] broken down for exactly what types of services," said study author Dr. Nicholas Zaorsky. He's an assistant professor of radiation oncology and public health sciences at Penn State Cancer Institute in Hershey, Pa.

"We wanted to look at what private insurances are paying for each kind of cancer and for each type of services," Zaorsky said in a college news release.

The researchers analyzed a nationwide database that included more than 402,000 privately insured cancer patients under age 65. The patients were treated in 2018 for lymphoma, melanoma, and cancers of the breast, prostate, colon, lung, uterus, head and neck, bladder, kidney, thyroid, stomach, liver, pancreas and esophagus.

In all, the patients received 38.4 million types of procedures and services. Breast cancer led the way with about 10.9 million, followed by colon cancer with about 3.9 million.

Breast cancer was the most expensive type of cancer ($3.4 billion), followed by lung cancer and colon cancer, both about $1.1 billion.

The $4 billion spent on drugs was the most expensive treatment category -- double the cost of cancer surgeries, according to findings published Oct. 6 in JAMA Network Open.

The study didn't assess whether treatments provided were cost-effective, but the findings may help guide future research into that area.

"It's hard to say like what is a reasonable price for a drug or service, but I think it's fair to say that they make up the plurality of our health care spending in the U.S., then some would argue that this money may be better spent elsewhere in other services," Zaorsky said. "These figures basically just show you how much the medical system spends on certain types of cancers versus another one."

He said one might ask if the costs are justified. For example, pancreatic cancer is one of the deadliest, Zaorsky said, but the total cost of care devoted to it is relatively low compared to something like indolent prostate cancer, which may exist for a long period without causing problems.

More information

The U.S. National Cancer Institute has more on cancer treatment.

SOURCE: Penn State College of Medicine, news release, Oct. 6, 2021